$0.71
0.0088[1.25%]
At close: Apr 24
$0.71
0[0.00%]
After Hours: 7:39PM EDT
Spruce Biosciences
(NASDAQ:SPRB)Latest News for Spruce Biosciences Stock (NASDAQ:SPRB)
Spruce Biosciences Stock (NASDAQ: SPRB)
Categories: All
Thursday, March 14, 2024
- Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock FreefallVandana Singh - Mar 14, 2024, 4:15PM
- Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top ViewsAvi Kapoor - Mar 14, 2024, 2:46PM
- Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Mar 14, 2024, 1:38PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Mar 14, 2024, 1:31PM
- Crude Oil Moves Higher; Dollar General Posts Upbeat EarningsAvi Kapoor - Mar 14, 2024, 12:14PM
- RBC Capital Downgrades Spruce Biosciences to Sector Perform, Lowers Price Target to $2Benzinga Newsdesk - Mar 14, 2024, 11:07AM
- US Stocks Higher; Producer Prices Rise 0.6% In FebruaryAvi Kapoor - Mar 14, 2024, 9:46AM
- HC Wainwright & Co. Downgrades Spruce Biosciences to NeutralBenzinga Newsdesk - Mar 14, 2024, 9:29AM
- Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?Vandana Singh - Mar 14, 2024, 9:19AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Mar 14, 2024, 9:06AM
- Leerink Partners Downgrades Spruce Biosciences to Market Perform, Lowers Price Target to $2Benzinga Newsdesk - Mar 14, 2024, 8:57AM
- JMP Securities Maintains Market Outperform on Spruce Biosciences, Lowers Price Target to $3Benzinga Newsdesk - Mar 14, 2024, 8:50AM
- Guggenheim Downgrades Spruce Biosciences to NeutralBenzinga Newsdesk - Mar 14, 2024, 8:38AM
- Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 14, 2024, 8:05AM
- Spruce Biosciences shares are trading lower after the company reported FY23 financial results. Also, the company announced that the CAHmedlia-203 study of Tildacerfont in adult classic congenital adrenal hyperplasia with severe hyperandrogenemia did not meet its primary efficacy endpoint.Benzinga Newsdesk - Mar 14, 2024, 7:58AM
Wednesday, March 13, 2024
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Mar 13, 2024, 5:32PM
- Spruce Biosciences Shares Resume TradeBenzinga Newsdesk - Mar 13, 2024, 4:40PM
- Trading Halt: Halt status updated at 4:35:00 PM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Mar 13, 2024, 4:35PM
- Spruce Biosciences Announces Resource Prioritization And Cost Reductions Including Reduction In Force Of ~21%Benzinga Newsdesk - Mar 13, 2024, 4:26PM
- Spruce Biosciences Reports FY23 EPS $(1.24) Vs $(1.96) YoY; Collaboration Revenue For The Year Ended December 31, 2023 Was $10.089MBenzinga Newsdesk - Mar 13, 2024, 4:16PM
- Spruce Biosciences Announces CAHmelia-203 Study Of Tildacerfont In Adult Classic Congenital Adrenal Hyperplasia With Severe Hyperandrogenemia Did Not Meet Primary Efficacy EndpointBenzinga Newsdesk - Mar 13, 2024, 4:02PM
- Trading Halt: Halted at 4:00:11 p.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Mar 13, 2024, 4:00PM
Tuesday, March 05, 2024
Monday, February 26, 2024
Wednesday, February 21, 2024
Tuesday, January 30, 2024
Friday, January 05, 2024
Thursday, January 04, 2024
Wednesday, November 29, 2023
Monday, November 20, 2023
Monday, November 13, 2023
Friday, October 20, 2023
Wednesday, October 18, 2023
Wednesday, September 13, 2023
Friday, September 08, 2023
- Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Sep 8, 2023, 1:56PM
- Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023Benzinga Insights - Sep 8, 2023, 11:00AM
- Analyst Ratings for Spruce BiosciencesBenzinga Insights - Sep 8, 2023, 10:01AM
- Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 8, 2023, 8:28AM
- Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For FridayLisa Levin - Sep 8, 2023, 8:24AM
- SVB Leerink Upgrades Spruce Biosciences to Outperform, Raises Price Target to $9Benzinga Newsdesk - Sep 8, 2023, 7:11AM